These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 12540057)
1. Cellular models for tau filament assembly. Ko LW; DeTure M; Sahara N; Chihab R; Yen SH J Mol Neurosci; 2002 Dec; 19(3):311-6. PubMed ID: 12540057 [TBL] [Abstract][Full Text] [Related]
2. Assembly of filamentous tau aggregates in human neuronal cells. Ko LW; Rush T; Sahara N; Kersh JS; Easson C; Deture M; Lin WL; Connor YD; Yen SH J Alzheimers Dis; 2004 Dec; 6(6):605-22; discussion 673-81. PubMed ID: 15665401 [TBL] [Abstract][Full Text] [Related]
3. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. Andorfer C; Kress Y; Espinoza M; de Silva R; Tucker KL; Barde YA; Duff K; Davies P J Neurochem; 2003 Aug; 86(3):582-90. PubMed ID: 12859672 [TBL] [Abstract][Full Text] [Related]
4. Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice. Guo JL; Narasimhan S; Changolkar L; He Z; Stieber A; Zhang B; Gathagan RJ; Iba M; McBride JD; Trojanowski JQ; Lee VM J Exp Med; 2016 Nov; 213(12):2635-2654. PubMed ID: 27810929 [TBL] [Abstract][Full Text] [Related]
5. Sources of extracellular tau and its signaling. Avila J; Simón D; Díaz-Hernández M; Pintor J; Hernández F J Alzheimers Dis; 2014; 40 Suppl 1():S7-S15. PubMed ID: 24531154 [TBL] [Abstract][Full Text] [Related]
6. Are tangles as toxic as they look? Spires-Jones TL; Kopeikina KJ; Koffie RM; de Calignon A; Hyman BT J Mol Neurosci; 2011 Nov; 45(3):438-44. PubMed ID: 21638071 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of tau self-aggregation and neurotoxicity. Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046 [TBL] [Abstract][Full Text] [Related]
8. Identification of key amino acids responsible for the distinct aggregation properties of microtubule-associated protein 2 and tau. Xie C; Soeda Y; Shinzaki Y; In Y; Tomoo K; Ihara Y; Miyasaka T J Neurochem; 2015 Oct; 135(1):19-26. PubMed ID: 26134402 [TBL] [Abstract][Full Text] [Related]
9. Toxic tau aggregation in AD. Takashima A Adv Exp Med Biol; 2015; 822():3-9. PubMed ID: 25416970 [No Abstract] [Full Text] [Related]
10. [Neuropathology of tauopathy]. Yoshida M Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of microtubule assembly competent tubulin synthesis leads to accumulation of phosphorylated tau in neuronal cell bodies. Fujiwara H; Watanabe S; Iwata M; Ueda S; Nobuhara M; Wada-Kakuda S; Misonou H; Miyasaka T Biochem Biophys Res Commun; 2020 Jan; 521(3):779-785. PubMed ID: 31699369 [TBL] [Abstract][Full Text] [Related]
12. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. Brandt R; Hundelt M; Shahani N Biochim Biophys Acta; 2005 Jan; 1739(2-3):331-54. PubMed ID: 15615650 [TBL] [Abstract][Full Text] [Related]
13. Systemic and network functions of the microtubule-associated protein tau: Implications for tau-based therapies. Bakota L; Ussif A; Jeserich G; Brandt R Mol Cell Neurosci; 2017 Oct; 84():132-141. PubMed ID: 28318914 [TBL] [Abstract][Full Text] [Related]
14. Intrinsically disordered tau protein in Alzheimer's tangles: a coincidence or a rule? Skrabana R; Skrabanova M; Csokova N; Sevcik J; Novak M Bratisl Lek Listy; 2006; 107(9-10):354-8. PubMed ID: 17262987 [TBL] [Abstract][Full Text] [Related]
15. Neurofibrillary degeneration can be arrested in an in vivo cellular model of human tauopathy by application of a compound which inhibits tau filament formation in vitro. Hall GF; Lee S; Yao J J Mol Neurosci; 2002 Dec; 19(3):253-60. PubMed ID: 12540050 [TBL] [Abstract][Full Text] [Related]
16. Distribution of spleen tyrosine kinase and tau phosphorylated at tyrosine 18 in a mouse model of tauopathy and in the human hippocampus. Köhler C; Fuhr V; Dinekov M Brain Res; 2017 Dec; 1677():1-13. PubMed ID: 28919467 [TBL] [Abstract][Full Text] [Related]
17. Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies. Reynolds MR; Reyes JF; Fu Y; Bigio EH; Guillozet-Bongaarts AL; Berry RW; Binder LI J Neurosci; 2006 Oct; 26(42):10636-45. PubMed ID: 17050703 [TBL] [Abstract][Full Text] [Related]
18. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies. Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231 [TBL] [Abstract][Full Text] [Related]
19. Dephosphorylation Targeting Chimaera (DEPTAC): Targeting Tau Proteins in Tauopathies. Soumbasis A; Eldeeb MA; Ragheb MA; Zorca CE Curr Protein Pept Sci; 2022; 23(3):129-132. PubMed ID: 35598241 [TBL] [Abstract][Full Text] [Related]
20. Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity. Zhao K; Ippolito G; Wang L; Price V; Kim MH; Cornwell G; Fulenchek S; Breen GA; Goux WJ; D'Mello SR J Neurosci Res; 2010 Nov; 88(15):3399-413. PubMed ID: 20882568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]